RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4479
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1245300; Gene model (P.falciparum): PF3D7_0530900; Gene product: formin 1
Name tag: EGFP
Phenotype Sporozoite;
Last modified: 16 August 2018, 16:59
  *RMgm-4479
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 30011270
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherDouglas RG, Frischknecht F
Name Group/DepartmentIntegrative Parasitology, Center for Infectious Diseases
Name InstituteHeidelberg University Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-4479
Principal nameFormin 1::eGFP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationNo
Phenotype
Asexual blood stageNot tested
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteThe mutant has not been analysed in detail. Formin 1::eGFP has a distinct localisation to the apical tip of the sporozoite
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal GFP-tagged version of formin-1

Protein (function)
Formin 1 is an actin binding protein (ABP) (and regulates actin polymerization)

Phenotype
The mutant has not been analysed in detail. Formin 1::eGFP has a distinct localisation to the apical tip of the sporozoite

Additional information

Other mutants

 


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1245300
Gene Model P. falciparum ortholog PF3D7_0530900
Gene productformin 1
Gene product: Alternative name
Details of the genetic modification
Name of the tagEGFP
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationIn order to generate the endogenous reversibly switchable enhanced GFP (rseGFP) Formin 1 (PBANKA_1245300) tag, the PlasmoGEM system was used. The intermediate stage tagging vector PbGEM-int-309594 was ordered from PlasmoGEM. Also, the recombination vector GW R6K Emerald was used. The coding region of rseGFP (vector pQE31, a kind gift of Mhlanga lab) was amplified with primers 17 and 18 and cloned with SacII and ApaI into the GW R6K Emerald vector, replacing the coding region of Emerald with rseGFP. The ligated vector was transformed into pir1 cells and the rseGFP sequenced. Using the Gateway reaction, the GW R6K vector and the intermediate vector PbGEM-int-309594 were combined and transformed into TSA cells.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6